AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vilbuzz Met 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Nirvana India Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vilbuzz Met 500mg/50mg Tablet

Metformin/Glibenclamide 500mg/50mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. This medication may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Maintaining blood sugar control prevents future complications. Continued commitment to the prescribed diet and exercise regimen is crucial. Lifestyle choices are integral to diabetes management. Common adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management. This medication isn't universally suitable. Prior to commencement, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation. Interaction with other medications is possible; complete medication disclosure to your doctor is essential for safe use. Alcohol consumption should be minimized due to its hypoglycemic effect. Renal function and blood glucose levels will be monitored regularly by your doctor.

Uses of Vilbuzz Met 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vilbuzz Met 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Vilbuzz Met 500mg/50mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Vilbuzz Met 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilbuzz Met 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vilbuzz Met 500mg/50mg tablets should be administered with a meal.

How Vilbuzz Met 500mg/50mg Tablet works:

Each Metformin/Glibenclamide 500mg/50mg Vilbuzz tablet combines two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Vilbuzz Met 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vilbuzz Met 500mg/50mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vilbuzz Met 500mg/50mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential drug transfer into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Vilbuzz Met 500mg/50mg tablets cautiously, as dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Vilbuzz Met 500mg/50mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vilbuzz Met 500mg/50mg Tablet :

Should you forget a Vilbuzz Met 500mg/50mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vilbuzz Met 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vilbuzz Met 500mg/50mg Tablet

Vilbuzz Met 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vilbuzz Met 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Vilbuzz Met 500mg/50mg Tablet is contraindicated in patients allergic to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vilbuzz Met 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vilbuzz Met 500mg/50mg Tablet can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vilbuzz Met and seek immediate medical attention.
Prolonged use of Vilbuzz Met 500mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vilbuzz Met 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your physician.
Vilbuzz Met 500mg/50mg Ta...
135
MRP 156
13% off